Bitget App
Trade smarter
Buy cryptoMarketsTradeFuturesEarnAISquareMore
Health Catalyst grants CEO Simeon Kohl 2,747,385 inducement RSUs under 2026 plan

Health Catalyst grants CEO Simeon Kohl 2,747,385 inducement RSUs under 2026 plan

ReutersReuters2026/09/14 22:33
  • Health Catalyst granted CEO and President Simeon Kohl 2,747,385 restricted stock units under its 2026 Employment Inducement Incentive Plan.
  • 915,975 RSUs vest on Sept. 14, 2027; the remainder vests in eight roughly equal quarterly installments, subject to continued employment.
  • Kohl bought 59,000 shares in open-market purchases on Sept. 11 and Sept. 14 at a weighted average price of $1.79.


Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Health Catalyst Inc. published the original content used to generate this news brief via GlobeNewswire (Ref. ID: 202609141832PRIMZONEFULLFEED9826721) on September 14, 2026, and is solely responsible for the information contained therein.

0
0

Disclaimer: The content of this article solely reflects the author's opinion and does not represent the platform in any capacity. This article is not intended to serve as a reference for making investment decisions.

Understand the market, then trade.
Bitget offers one-stop trading for cryptocurrencies, stocks, and gold.
Trade now!

You may also like

VIX soars to 18, options volume doubles: traders bet "AI risks are scarier than Fed rate hikes"

US equities options traders believe that debates over the pace of AI development pose a greater disruptive risk than Federal Reserve rate hikes. The volume of VIX options has doubled, with funds aggressively hedging against the risk of sharp fluctuations in technology stocks.

智通财经2026/09/15 01:41
VIX soars to 18, options volume doubles: traders bet "AI risks are scarier than Fed rate hikes"

GLJ gives GE Vernova (GEV.US) a "Sell" rating: $470 target price is the lowest on Wall Street, bluntly stating that "cyclical industrial stocks are being priced like software stocks"

GLJ Research has given GE Vernova a "sell" rating and set the lowest target price on Wall Street at $470, stating that the company is "a cyclical gas turbine manufacturer priced like a long-term compound growth stock."

智通财经2026/09/15 01:41
GLJ gives GE Vernova (GEV.US) a "Sell" rating: $470 target price is the lowest on Wall Street, bluntly stating that "cyclical industrial stocks are being priced like software stocks"